Jeremy Colgan
Family Medicine · Northern Cambria, PANPI 1235206574
Payments from drug & device makers
Across 413 payments — averaging $16.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Amgen$516
- Novo Nordisk$455
- AstraZeneca$445
- Paratek Pharmaceuticals, Inc.$365
- Boehringer Ingelheim$336
- plus $3K from 29 others
What the payments were for
- Food & beverage$6,54099%
- Education$851%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 88 | $1,089 |
| Amgen | 31 | $516 |
| Novo Nordisk | 28 | $455 |
| AstraZeneca | 23 | $445 |
| Paratek Pharmaceuticals, Inc. | 22 | $365 |
| Boehringer Ingelheim | 20 | $336 |
| Lilly USA, LLC | 18 | $288 |
| Biohaven Pharmaceuticals, Inc. | 19 | $287 |
| Abbott | 14 | $278 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $233 |
| Novartis | 11 | $205 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 12 | $192 |
| Phathom Pharmaceuticals, Inc. | 10 | $181 |
| GSK | 11 | $172 |
| Exact Sciences | 9 | $169 |
| Kowa Pharmaceuticals America, Inc. | 11 | $164 |
| Pfizer | 10 | $161 |
| Amarin Pharma, Inc. | 10 | $140 |
| Merck | 9 | $131 |
| Ardelyx, Inc. | 4 | $113 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $111 |
| Esperion Therapeutics, Inc. | 6 | $94 |
| Astellas Pharma US Inc | 1 | $85 |
| E.r. Squibb & Sons, L.L.C. | 4 | $72 |
| Verona Pharma, Inc. | 4 | $62 |
| Johnson & Johnson | 4 | $56 |
| Shield Therapeutics Inc | 2 | $48 |
| Acadia Pharmaceuticals Inc | 2 | $37 |
| Sanofi-aventis U.S. LLC | 2 | $34 |
| Dexcom, Inc. | 2 | $26 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
| Inspire Medical Systems, Inc. | 1 | $18 |
| Xeris Pharmaceuticals, Inc. | 1 | $18 |
| Sanofi Pasteur Inc. | 1 | $14 |
| Idorsia Pharmaceuticals US Inc | 1 | $13 |
How this compares
$6,625 in reported general payments places this provider in the 90th percentile of 4,967 family medicine providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 99 | $91,430 |
| EliquisApixaban | 135 | $90,528 |
| FarxigaDapagliflozin Propanediol | 114 | $71,508 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 40 | $41,534 |
| XifaxanRifaximin | 12 | $35,976 |
| Repatha SureclickEvolocumab | 65 | $34,265 |
| MyrbetriqMirabegron | 52 | $27,517 |
| TrulicityDulaglutide | 28 | $27,475 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 39 | $26,150 |
| SynjardyEmpagliflozin/Metformin Hcl | 32 | $24,753 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 21 | $21,257 |
| XareltoRivaroxaban | 30 | $17,639 |
| TradjentaLinagliptin | 28 | $17,099 |
| XolairOmalizumab | 12 | $16,792 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 19 | $15,025 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Synjardy Xr, Synjardy, Tradjenta, Trijardy Xr | $336 | $186,679220 claims |
| PfizerEliquis, Nurtec Odt | $161 | $102,519148 claims |
| AstraZenecaFarxiga, Brilinta | $445 | $81,422126 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan | $192 | $35,97612 claims |
| Johnson & JohnsonXarelto, Invokamet, Invokana | $56 | $31,21954 claims |
| Astellas Pharma US IncMyrbetriq | $85 | $27,51752 claims |
| Lilly USA, LLCTrulicity | $288 | $27,47528 claims |
| GSKTrelegy Ellipta | $172 | $26,15039 claims |
| MerckJanumet Xr | $131 | $15,02519 claims |
| AbbVieLinzess | $1,089 | $8,79513 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,967 family medicine providers in Pennsylvania.
Other family medicine in Northern Cambria
- Kem YenalPhila$12.6M
- Marcy FleckerSmithfield$6.9M
- Tiffany PlutoScottdale$4.8M
- Bryce PalchickPittsburgh$4.7M
- Harris CohenHorsham$3.7M
- Shari RozenPittsburgh$2.9M
- Richard CookUniontown$2.1M
- Bruce GebhardtErie$2.1M
- Peter CognettiScranton$1.9M
- Bradley FoxErie$1.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.